+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Peptide Antibiotics Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type

  • PDF Icon

    Report

  • 115 Pages
  • November 2023
  • Region: Global
  • Prof Research
  • ID: 5900786

Quick Summary:

In an era of burgeoning healthcare demands, the global market for Peptide Antibiotics has witnessed substantial growth and is anticipated to continue to prosper into the future. This comprehensive report provides an in-depth analysis of the market landscape, equipping businesses with invaluable insights that can significantly impact strategic decision making.

Our meticulous research encompasses the entire geographical spectrum including North America, South America, Asia & Pacific, Europe, and MEA, with granular data on major countries within these regions. From the biggest players in the sector like Pfizer and Novartis, to emerging contenders, this report examines the performance, market share and strategies of major players in the Peptide Antibiotics field. The report also shines a spotlight on the market's diverse applications, ranging from healthcare and food, to commodities and more. Armed with these insights, executives can make informed decisions regarding future investments.

This report describes the global market size of Peptide Antibiotics from 2018 to 2022 and its CAGR from 2018 to 2022, and also forecasts its market size to the end of 2028 and its CAGR from 2023 to 2028.

For the geography segment, regional supply, demand, major players, price is presented from 2018 to 2028.
This report covers the following regions:

  • North America
  • South America
  • Asia & Pacific
  • Europe
  • MEA
The key countries for each region are also included such as the United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.

For the competitor segment, the report includes global key players of Peptide Antibiotics as well as some small players.
The information for each competitor includes:

  • Company Profile
  • Business Information
  • SWOT Analysis
  • Revenue, Gross Margin and Market Share

Applications Segment:

  • Pharma& Healthcare
  • Food
  • Commodities
  • Other

Types Segment:

  • Ribosomal Synthesized Peptide Antibiotics
  • Non-Ribosomally Synthesized Peptide Antibiotics

Companies Covered:

  • Pfizer
  • Novartis
  • GlaxoSmithKline
  • Eli Lilly
  • Theravance
  • Vicuron Pharmaceuticals
  • Savara Pharmaceuticals
  • AMP Therapeutics
  • Hospira
  • Kasten
Base Year: 2023
Historical Data: from 2018 to 2022
Forecast Data: from 2023 to 2028


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Executive Summary
Chapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter Four Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
5.6 Covid-19 Impact
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Peptide Antibiotics Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Peptide Antibiotics Market in North America (2018-2028)
8.1 Peptide Antibiotics Market Size
8.2 Peptide Antibiotics Market by End Use
8.3 Competition by Players/Suppliers
8.4 Peptide Antibiotics Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Peptide Antibiotics Market in South America (2018-2028)
9.1 Peptide Antibiotics Market Size
9.2 Peptide Antibiotics Market by End Use
9.3 Competition by Players/Suppliers
9.4 Peptide Antibiotics Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast Peptide Antibiotics Market in Asia & Pacific (2018-2028)
10.1 Peptide Antibiotics Market Size
10.2 Peptide Antibiotics Market by End Use
10.3 Competition by Players/Suppliers
10.4 Peptide Antibiotics Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southeast Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Peptide Antibiotics Market in Europe (2018-2028)
11.1 Peptide Antibiotics Market Size
11.2 Peptide Antibiotics Market by End Use
11.3 Competition by Players/Suppliers
11.4 Peptide Antibiotics Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Peptide Antibiotics Market in MEA (2018-2028)
12.1 Peptide Antibiotics Market Size
12.2 Peptide Antibiotics Market by End Use
12.3 Competition by Players/Suppliers
12.4 Peptide Antibiotics Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global Peptide Antibiotics Market (2018-2023)
13.1 Peptide Antibiotics Market Size
13.2 Peptide Antibiotics Market by End Use
13.3 Competition by Players/Suppliers
13.4 Peptide Antibiotics Market Size by Type
Chapter 14 Global Peptide Antibiotics Market Forecast (2023-2028)
14.1 Peptide Antibiotics Market Size Forecast
14.2 Peptide Antibiotics Application Forecast
14.3 Competition by Players/Suppliers
14.4 Peptide Antibiotics Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 Pfizer
15.1.1 Company Profile
15.1.2 Main Business and Peptide Antibiotics Information
15.1.3 SWOT Analysis of Pfizer
15.1.4 Pfizer Peptide Antibiotics Revenue, Gross Margin and Market Share (2018-2023)
15.2 Novartis
15.2.1 Company Profile
15.2.2 Main Business and Peptide Antibiotics Information
15.2.3 SWOT Analysis of Novartis
15.2.4 Novartis Peptide Antibiotics Revenue, Gross Margin and Market Share (2018-2023)
15.3 GlaxoSmithKline
15.3.1 Company Profile
15.3.2 Main Business and Peptide Antibiotics Information
15.3.3 SWOT Analysis of GlaxoSmithKline
15.3.4 GlaxoSmithKline Peptide Antibiotics Revenue, Gross Margin and Market Share (2018-2023)
15.4 Eli Lilly
15.4.1 Company Profile
15.4.2 Main Business and Peptide Antibiotics Information
15.4.3 SWOT Analysis of Eli Lilly
15.4.4 Eli Lilly Peptide Antibiotics Revenue, Gross Margin and Market Share (2018-2023)
15.5 Theravance
15.5.1 Company Profile
15.5.2 Main Business and Peptide Antibiotics Information
15.5.3 SWOT Analysis of Theravance
15.5.4 Theravance Peptide Antibiotics Revenue, Gross Margin and Market Share (2018-2023)
15.6 Vicuron Pharmaceuticals
15.6.1 Company Profile
15.6.2 Main Business and Peptide Antibiotics Information
15.6.3 SWOT Analysis of Vicuron Pharmaceuticals
15.6.4 Vicuron Pharmaceuticals Peptide Antibiotics Revenue, Gross Margin and Market Share (2018-2023)
15.7 Savara Pharmaceuticals
15.7.1 Company Profile
15.7.2 Main Business and Peptide Antibiotics Information
15.7.3 SWOT Analysis of Savara Pharmaceuticals
15.7.4 Savara Pharmaceuticals Peptide Antibiotics Revenue, Gross Margin and Market Share (2018-2023)
15.8 AMP Therapeutics
15.8.1 Company Profile
15.8.2 Main Business and Peptide Antibiotics Information
15.8.3 SWOT Analysis of AMP Therapeutics
15.8.4 AMP Therapeutics Peptide Antibiotics Revenue, Gross Margin and Market Share (2018-2023)
15.9 Hospira
15.9.1 Company Profile
15.9.2 Main Business and Peptide Antibiotics Information
15.9.3 SWOT Analysis of Hospira
15.9.4 Hospira Peptide Antibiotics Revenue, Gross Margin and Market Share (2018-2023)
15.10 Kasten
15.10.1 Company Profile
15.10.2 Main Business and Peptide Antibiotics Information
15.10.3 SWOT Analysis of Kasten
15.10.4 Kasten Peptide Antibiotics Revenue, Gross Margin and Market Share (2018-2023)
Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Peptide Antibiotics Report
Table Data Sources of Peptide Antibiotics Report
Table Major Assumptions of Peptide Antibiotics Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Peptide Antibiotics Picture
Table Peptide Antibiotics Classification
Table Peptide Antibiotics Applications
Table Drivers of Peptide Antibiotics Market
Table Restraints of Peptide Antibiotics Market
Table Opportunities of Peptide Antibiotics Market
Table Threats of Peptide Antibiotics Market
Table Covid-19 Impact For Peptide Antibiotics Market
Table Raw Materials Suppliers
Table Different Production Methods of Peptide Antibiotics
Table Cost Structure Analysis of Peptide Antibiotics
Table Key End Users
Table Latest News of Peptide Antibiotics Market
Table Merger and Acquisition
Table Planned/Future Project of Peptide Antibiotics Market
Table Policy of Peptide Antibiotics Market
Table 2018-2028 North America Peptide Antibiotics Market Size
Figure 2018-2028 North America Peptide Antibiotics Market Size and CAGR
Table 2018-2028 North America Peptide Antibiotics Market Size by Application
Table 2018-2023 North America Peptide Antibiotics Key Players Revenue
Table 2018-2023 North America Peptide Antibiotics Key Players Market Share
Table 2018-2028 North America Peptide Antibiotics Market Size by Type
Table 2018-2028 United States Peptide Antibiotics Market Size
Table 2018-2028 Canada Peptide Antibiotics Market Size
Table 2018-2028 Mexico Peptide Antibiotics Market Size
Table 2018-2028 South America Peptide Antibiotics Market Size
Figure 2018-2028 South America Peptide Antibiotics Market Size and CAGR
Table 2018-2028 South America Peptide Antibiotics Market Size by Application
Table 2018-2023 South America Peptide Antibiotics Key Players Revenue
Table 2018-2023 South America Peptide Antibiotics Key Players Market Share
Table 2018-2028 South America Peptide Antibiotics Market Size by Type
Table 2018-2028 Brazil Peptide Antibiotics Market Size
Table 2018-2028 Argentina Peptide Antibiotics Market Size
Table 2018-2028 Chile Peptide Antibiotics Market Size
Table 2018-2028 Peru Peptide Antibiotics Market Size
Table 2018-2028 Asia & Pacific Peptide Antibiotics Market Size
Figure 2018-2028 Asia & Pacific Peptide Antibiotics Market Size and CAGR
Table 2018-2028 Asia & Pacific Peptide Antibiotics Market Size by Application
Table 2018-2023 Asia & Pacific Peptide Antibiotics Key Players Revenue
Table 2018-2023 Asia & Pacific Peptide Antibiotics Key Players Market Share
Table 2018-2028 Asia & Pacific Peptide Antibiotics Market Size by Type
Table 2018-2028 China Peptide Antibiotics Market Size
Table 2018-2028 India Peptide Antibiotics Market Size
Table 2018-2028 Japan Peptide Antibiotics Market Size
Table 2018-2028 South Korea Peptide Antibiotics Market Size
Table 2018-2028 Southeast Asia Peptide Antibiotics Market Size
Table 2018-2028 Australia Peptide Antibiotics Market Size
Table 2018-2028 Europe Peptide Antibiotics Market Size
Figure 2018-2028 Europe Peptide Antibiotics Market Size and CAGR
Table 2018-2028 Europe Peptide Antibiotics Market Size by Application
Table 2018-2023 Europe Peptide Antibiotics Key Players Revenue
Table 2018-2023 Europe Peptide Antibiotics Key Players Market Share
Table 2018-2028 Europe Peptide Antibiotics Market Size by Type
Table 2018-2028 Germany Peptide Antibiotics Market Size
Table 2018-2028 France Peptide Antibiotics Market Size
Table 2018-2028 United Kingdom Peptide Antibiotics Market Size
Table 2018-2028 Italy Peptide Antibiotics Market Size
Table 2018-2028 Spain Peptide Antibiotics Market Size
Table 2018-2028 Belgium Peptide Antibiotics Market Size
Table 2018-2028 Netherlands Peptide Antibiotics Market Size
Table 2018-2028 Austria Peptide Antibiotics Market Size
Table 2018-2028 Poland Peptide Antibiotics Market Size
Table 2018-2028 Russia Peptide Antibiotics Market Size
Table 2018-2028 MEA Peptide Antibiotics Market Size
Figure 2018-2028 MEA Peptide Antibiotics Market Size and CAGR
Table 2018-2028 MEA Peptide Antibiotics Market Size by Application
Table 2018-2023 MEA Peptide Antibiotics Key Players Revenue
Table 2018-2023 MEA Peptide Antibiotics Key Players Market Share
Table 2018-2028 MEA Peptide Antibiotics Market Size by Type
Table 2018-2028 Egypt Peptide Antibiotics Market Size
Table 2018-2028 Israel Peptide Antibiotics Market Size
Table 2018-2028 South Africa Peptide Antibiotics Market Size
Table 2018-2028 Gulf Cooperation Council Countries Peptide Antibiotics Market Size
Table 2018-2028 Turkey Peptide Antibiotics Market Size
Table 2018-2023 Global Peptide Antibiotics Market Size by Region
Table 2018-2023 Global Peptide Antibiotics Market Size Share by Region
Table 2018-2023 Global Peptide Antibiotics Market Size by Application
Table 2018-2023 Global Peptide Antibiotics Market Share by Application
Table 2018-2023 Global Peptide Antibiotics Key Vendors Revenue
Figure 2018-2023 Global Peptide Antibiotics Market Size and Growth Rate
Table 2018-2023 Global Peptide Antibiotics Key Vendors Market Share
Table 2018-2023 Global Peptide Antibiotics Market Size by Type
Table 2018-2023 Global Peptide Antibiotics Market Share by Type
Table 2023-2028 Global Peptide Antibiotics Market Size by Region
Table 2023-2028 Global Peptide Antibiotics Market Size Share by Region
Table 2023-2028 Global Peptide Antibiotics Market Size by Application
Table 2023-2028 Global Peptide Antibiotics Market Share by Application
Table 2023-2028 Global Peptide Antibiotics Key Vendors Revenue
Figure 2023-2028 Global Peptide Antibiotics Market Size and Growth Rate
Table 2023-2028 Global Peptide Antibiotics Key Vendors Market Share
Table 2023-2028 Global Peptide Antibiotics Market Size by Type
Table 2023-2028 Peptide Antibiotics Global Market Share by Type

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Pfizer
  • Novartis
  • GlaxoSmithKline
  • Eli Lilly
  • Theravance
  • Vicuron Pharmaceuticals
  • Savara Pharmaceuticals
  • AMP Therapeutics
  • Hospira
  • Kasten

Methodology

Loading
LOADING...